Fangda Partners acted as the PRC legal counsel to Akeso, Inc. on the offering. Akeso, Inc. completed the issuance of 31,700,000 shares on the Main Board...
You must be a Standard 1 Year member to access this content.
Fangda, Davis Polk and Conyers advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed a successful listing on the Shanghai Stock Exchange’s STAR Market. InnoCare...
You must be a Standard 1 Year member to access this content.
Fangda advised Zoomlion Heavy Industry Science and Technology on the deal. Zoomlion Heavy Industry Science and Technology Co., Ltd. executed the acquisition of the controlling stake...
You must be a Standard 1 Year member to access this content.
Fangda Partners advised BeiGene, while Davis Polk advised the representatives of the several underwriters on the deal. BeiGene executed a US$3.5 billion initial public offering and listing...
You must be a Standard 1 Year member to access this content.
